Cabaletta Bio Statistics
Total Valuation
Cabaletta Bio has a market cap or net worth of $156.41 million. The enterprise value is -$13.38 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Cabaletta Bio has 91.47 million shares outstanding. The number of shares has increased by 11.81% in one year.
Current Share Class | 91.47M |
Shares Outstanding | 91.47M |
Shares Change (YoY) | +11.81% |
Shares Change (QoQ) | +21.94% |
Owned by Insiders (%) | 1.65% |
Owned by Institutions (%) | 44.99% |
Float | 81.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.88 |
P/TBV Ratio | 0.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.14.
Current Ratio | 4.78 |
Quick Ratio | 4.69 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -92.92 |
Financial Efficiency
Return on equity (ROE) is -76.34% and return on invested capital (ROIC) is -45.66%.
Return on Equity (ROE) | -76.34% |
Return on Assets (ROA) | -42.39% |
Return on Invested Capital (ROIC) | -45.66% |
Return on Capital Employed (ROCE) | -81.92% |
Revenue Per Employee | n/a |
Profits Per Employee | -$879,793 |
Employee Count | 164 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.96% in the last 52 weeks. The beta is 2.74, so Cabaletta Bio's price volatility has been higher than the market average.
Beta (5Y) | 2.74 |
52-Week Price Change | -60.96% |
50-Day Moving Average | 1.71 |
200-Day Moving Average | 2.12 |
Relative Strength Index (RSI) | 57.71 |
Average Volume (20 Days) | 1,303,091 |
Short Selling Information
The latest short interest is 6.03 million, so 6.59% of the outstanding shares have been sold short.
Short Interest | 6.03M |
Short Previous Month | 6.54M |
Short % of Shares Out | 6.59% |
Short % of Float | 7.43% |
Short Ratio (days to cover) | 4.49 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -149.87M |
Pretax Income | -89.98M |
Net Income | -144.29M |
EBITDA | -148.03M |
EBIT | -149.87M |
Earnings Per Share (EPS) | -$2.75 |
Full Income Statement Balance Sheet
The company has $194.68 million in cash and $24.89 million in debt, giving a net cash position of $169.79 million or $1.86 per share.
Cash & Cash Equivalents | 194.68M |
Total Debt | 24.89M |
Net Cash | 169.79M |
Net Cash Per Share | $1.86 |
Equity (Book Value) | 178.48M |
Book Value Per Share | 1.95 |
Working Capital | 156.87M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$104.67 million and capital expenditures -$1.58 million, giving a free cash flow of -$106.25 million.
Operating Cash Flow | -104.67M |
Capital Expenditures | -1.58M |
Free Cash Flow | -106.25M |
FCF Per Share | -$1.16 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Cabaletta Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.81% |
Shareholder Yield | -11.81% |
Earnings Yield | -92.25% |
FCF Yield | -67.93% |
Analyst Forecast
The average price target for Cabaletta Bio is $14.29, which is 735.67% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.29 |
Price Target Difference | 735.67% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -24.02% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |